-
3
-
-
0030431577
-
2A antagonist with a favorable CNS safety profile
-
2A antagonist with a favorable CNS safety profile. J Pharmacol Exp Ther 277:968-981
-
(1996)
J Pharmacol Exp Ther
, vol.277
, pp. 968-981
-
-
Kehne, J.H.1
Baron, B.M.2
Carr, A.A.3
Chaney, S.F.4
Elands, J.5
Feldman, D.J.6
Frank, R.A.7
Van Giersbergen, P.L.M.8
McCloskey, T.C.9
Johnson, M.P.10
McCarty, D.R.11
Poirot, M.12
Senyah, Y.13
Siegel, B.W.14
Widmaier, C.15
-
4
-
-
0027033885
-
2 receptors
-
Graumann J, Drukker J (eds). Fischer, New York
-
2 receptors. In: Graumann J, Drukker J (eds) Progress in histo- and cytochemistry, histochemistry of receptors. Fischer, New York, pp 241-249
-
(1992)
Progress in Histo- and Cytochemistry, Histochemistry of Receptors
, pp. 241-249
-
-
Leysen, J.E.1
Schotte, A.2
-
6
-
-
0020004528
-
2 receptor binding sites. Binding properties, brain distribution, and functional role
-
2 receptor binding sites. Binding properties, brain distribution, and functional role. Mol Pharmacol 21:301-314
-
(1982)
Mol Pharmacol
, vol.21
, pp. 301-314
-
-
Leysen, J.E.1
Niemegeers, C.J.E.2
Van Nueten, J.M.3
Laduron, P.M.4
-
7
-
-
0023818724
-
3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets: Relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs
-
3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets: Relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs. J Pharmacol Exp Ther 244:310-321
-
(1988)
J Pharmacol Exp Ther
, vol.244
, pp. 310-321
-
-
Leysen, J.E.1
Eens, A.2
Gommeren, W.3
Van Compel, P.4
Wynants, J.5
Janssen, P.A.J.6
-
9
-
-
0025993053
-
2 antagonists
-
2 antagonists. J Med Chem 34:2477-2483
-
(1991)
J Med Chem
, vol.34
, pp. 2477-2483
-
-
Malleron, J.-L.1
Comte, M.-T.2
Gueremy, C.3
Peyronel, J.F.4
Truchon, A.5
Blanchard, J.C.6
Doble, A.7
Piot, O.8
Zundel, J.-L.9
Huon, C.10
Martin, B.11
Mouton, P.12
Viroulaud, A.13
Allam, D.14
Betschart, J.15
-
13
-
-
0022401097
-
Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors
-
Pazos A, Cortés R, Palacios JM (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res 346:231-249
-
(1985)
Brain Res
, vol.346
, pp. 231-249
-
-
Pazos, A.1
Cortés, R.2
Palacios, J.M.3
-
14
-
-
0028261434
-
Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors
-
Roth BL, Craigo SC, Choudharry MS, Uluer A, Monsma FJ, Shen Y, Meltzer HY, Sibley DR (1994) Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther 268:1403-1410
-
(1994)
J Pharmacol Exp Ther
, vol.268
, pp. 1403-1410
-
-
Roth, B.L.1
Craigo, S.C.2
Choudharry, M.S.3
Uluer, A.4
Monsma, F.J.5
Shen, Y.6
Meltzer, H.Y.7
Sibley, D.R.8
-
16
-
-
0026613672
-
2 receptors exert a state-dependent regulation of dopaminergic function: Studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine
-
2 receptors exert a state-dependent regulation of dopaminergic function: Studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine. Eur J Pharmacol 223:65-74
-
(1992)
Eur J Pharmacol
, vol.223
, pp. 65-74
-
-
Schmidt, C.J.1
Fadayel, G.M.2
Sullivan, C.K.3
Taylor, V.L.4
-
17
-
-
0027723207
-
2 receptors in schizophrenia and antipsychotic activity
-
2 receptors in schizophrenia and antipsychotic activity. Int Clin Psychopharmacol 8 [Suppl 2]:25-32
-
(1993)
Int Clin Psychopharmacol
, vol.8
, Issue.2 SUPPL.
, pp. 25-32
-
-
Schmidt, C.J.1
Kehne, J.H.2
Carr, A.A.3
Fadayel, G.M.4
Humphreys, T.M.5
Ketteler, H.J.6
McCloskey, T.C.7
Padich, R.A.8
Taylor, V.L.9
Sorensen, S.M.10
-
18
-
-
0028176861
-
2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine
-
2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine. J Neurochem 62:1382-1389
-
(1994)
J Neurochem
, vol.62
, pp. 1382-1389
-
-
Schmidt, C.J.1
Sullivan, C.K.2
Fadayel, G.M.3
-
22
-
-
0027340586
-
2 receptor antagonist MDL 100,907 as a putative atypical antipsychotic: Behavioral, electrophysiological and neurochemical studies
-
2 receptor antagonist MDL 100,907 as a putative atypical antipsychotic: Behavioral, electrophysiological and neurochemical studies. J Pharmacol Exp Ther 266:684-691
-
(1993)
J Pharmacol Exp Ther
, vol.266
, pp. 684-691
-
-
Sorensen, S.M.1
Kehne, J.H.2
Fadayel, G.M.3
Humphreys, T.M.4
Ketteler, H.J.5
Sullivan, C.K.6
Taylor, V.L.7
Schmidt, C.J.8
|